Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Cost of Revenue (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Cost of Revenue for 16 consecutive years, with $188.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 23.86% year-over-year to $188.8 million, compared with a TTM value of $840.7 million through Dec 2025, down 21.41%, and an annual FY2025 reading of $840.7 million, down 21.41% over the prior year.
  • Cost of Revenue was $188.8 million for Q4 2025 at Cross Country Healthcare, down from $199.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $613.9 million in Q1 2022 and bottomed at $188.8 million in Q4 2025.
  • Average Cost of Revenue over 5 years is $348.0 million, with a median of $296.5 million recorded in 2021.
  • The sharpest move saw Cost of Revenue surged 206.13% in 2021, then tumbled 37.54% in 2024.
  • Year by year, Cost of Revenue stood at $493.5 million in 2021, then dropped by 0.86% to $489.3 million in 2022, then plummeted by 33.87% to $323.5 million in 2023, then dropped by 23.37% to $247.9 million in 2024, then fell by 23.86% to $188.8 million in 2025.
  • Business Quant data shows Cost of Revenue for CCRN at $188.8 million in Q4 2025, $199.1 million in Q3 2025, and $218.1 million in Q2 2025.